newsfilter
← Latest News
GlobeNewswire·

Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

  • Serina Therapeutics (NYSE: SER) announced CEO Steve Ledger will present at the H.C. Wainwright 28th Annual Global Investment Conference.
  • The conference will take place September 14-16, 2026, in New York, New York, featuring one-on-one investor meetings.
  • On-demand viewing of the presentation begins Monday, September 14, 2026, at 7:00 a.m. ET.
  • Serina is a clinical-stage biotechnology company utilizing its proprietary POZ Platform™ to optimize drug candidates for neurological diseases.
  • The platform improves efficacy & safety profiles for small molecules, RNA-based therapeutics, & antibody-drug conjugates.
  • Lead program SER-252 (POZ-apomorphine) is being developed as a long-acting treatment for advanced Parkinson's disease.